d consumer health and wellness products and holds leading brand positions in all of its key product categories. Amerifit products are sold in most major mass, club, drug, grocery and specialty stores and include: Culturelle®, a leading probiotic supplement; AZO, the leading OTC brand addressing symptom relief and detection of urinary tract infections; and Estroven®, the leading all-natural nutritional supplement brand addressing the symptoms of menopause. Martek currently has a number of nutritional health and wellness products under development that it plans to commercialize and distribute through Amerifit's distribution channels.
Martek's technology platform has also made it a sought-after partner on a range of groundbreaking projects in process, including the development of microbially-derived biofuels and the development of DHA-containing oilseeds. For more information on Martek Biosciences, visit http://www.martek.com/. For a complete list of life'sDHA™ and life'sARA™ products, visit http://www.lifesdha.com/. For more information about Amerifit Brands, visit http://www.amerifit.com.MARTEK BIOSCIENCES CORPORATIONSummary Consolidated Financial Information
(Unaudited - $ in thousands, except per share data)Unaudited Condensed Consolidated Statements of Income DataThree months ended
October 31, Year ended
October 31,20102009 20102009Revenues:Product sales
$
117,613$
81,917$
434,752$
329,135Contract manufacturing and services1,5235,67215,27116,062Total revenues119,13687,589450,023345,197Cost of revenues:Cost of product sales56,05245,048220,362182,385Cost of contract manufacturing and services9314,15112,90814,252Total cost of revenues56,98349,199233,270196,637Gross margin62,15338,390216,753148,560Operating expenses:Resea
'/>"/>
SOURCE Martek Biosciences Corporation Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 Related biology technology :1.
Martek to Present at Upcoming Citi Small / Mid Cap Conference2.
Martek to Present at Upcoming UBS Conference3.
Martek Announces Third Quarter FY 2010 Financial Results4.
Martek Announces Fourth Quarter and FY 2009 Financial Results5.
Martek Signs Sole-Source Supply Agreement with Fonterra6.
Martek to Announce Fourth Quarter and Fiscal Year 2009 Results7.
Martek Announces Addition to Its Board of Directors8.
Martek to Present at Two Upcoming Investor Conferences9.
Martek Announces Settlement of Patent Dispute with Capsugel France10.
Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case11.
Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions